Literature DB >> 10342595

Characteristics and prognosis of epilepsy in children with cerebral palsy.

D I Zafeiriou1, E E Kontopoulos, I Tsikoulas.   

Abstract

The aims of the study were to describe the prevalence and characteristics of epilepsy in a population of patients with cerebral palsy in a university referral center and to determine the rate of relapse caused by discontinuation of antiepileptic drugs after a 3-year seizure-free period. A total of 178 consecutive patients with cerebral palsy and epilepsy were prospectively followed for 9.2 +/- 2.4 years after onset of seizures and compared to a control group of 150 epileptic patients without cerebral palsy (median follow-up period, 10.5 years). The overall prevalence of epilepsy was 36.1%. Patients with atonic-diplegic, dystonic, tetraplegic, and hemiplegic cerebral palsy had a higher incidence of epilepsy (87.5%, 87.1%, 56.5%, and 42%, respectively). In all, 134 (75.3%) patients were seizure free for more than 3 years and could discontinue therapy, whereas 44 patients (24.7%) were still on antiepileptic drugs. Eighteen of 134 patients relapsed after a 3-year seizure-free period and subsequent discontinuation of antiepileptic drugs, thus giving a relapse rate of 13.4%. First seizures occurred during the first year of life in 69.7% of the patients with epilepsy and cerebral palsy. Complete control of seizures could be achieved in 65.2% of the patients with cerebral palsy and epilepsy; however, regardless of the prognosis of seizures, epilepsy was a major prognostic factor regarding both the presence of mental retardation and the motor development of children with cerebral palsy.

Entities:  

Mesh:

Year:  1999        PMID: 10342595     DOI: 10.1177/088307389901400504

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  9 in total

1.  A Brain-Heart Biomarker for Epileptogenesis.

Authors:  Fatemeh Bahari; Paddy Ssentongo; Steven J Schiff; Bruce J Gluckman
Journal:  J Neurosci       Date:  2018-08-27       Impact factor: 6.167

2.  Risk of seizures associated with antipsychotic treatment in pediatrics with psychiatric disorders: a nested case-control study in Korea.

Authors:  Soo Min Jeon; Susan Park; Dohoon Kim; Jin-Won Kwon
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-04-07       Impact factor: 4.785

3.  Association of cerebral palsy with other disabilities in children with perinatal arterial ischemic stroke.

Authors:  Meredith R Golomb; Chandan Saha; Bhuwan P Garg; Faouzi Azzouz; Linda S Williams
Journal:  Pediatr Neurol       Date:  2007-10       Impact factor: 3.372

4.  Cognition and bimanual performance in children with unilateral cerebral palsy: protocol for a multicentre, cross-sectional study.

Authors:  Brian Hoare; Michael Ditchfield; Megan Thorley; Margaret Wallen; Jenny Bracken; Adrienne Harvey; Catherine Elliott; Iona Novak; Ali Crichton
Journal:  BMC Neurol       Date:  2018-05-08       Impact factor: 2.474

Review 5.  Cerebral palsy: comprehensive review and update.

Authors:  Mohammed M S Jan
Journal:  Ann Saudi Med       Date:  2006 Mar-Apr       Impact factor: 1.526

6.  Evaluation of Risk Factors for Epilepsy in Pediatric Patients with Cerebral Palsy.

Authors:  Małgorzata Sadowska; Beata Sarecka-Hujar; Ilona Kopyta
Journal:  Brain Sci       Date:  2020-07-25

Review 7.  Cerebral Palsy: Current Opinions on Definition, Epidemiology, Risk Factors, Classification and Treatment Options.

Authors:  Małgorzata Sadowska; Beata Sarecka-Hujar; Ilona Kopyta
Journal:  Neuropsychiatr Dis Treat       Date:  2020-06-12       Impact factor: 2.570

8.  Risk Factors of Intractable Epilepsy in Children with Cerebral Palsy.

Authors:  Yehia Hamed Abdel Maksoud; Hany Abdelaziz Suliman; Sameh ElSAYED Abdulsamea; Naglaa Mohamed Kamal; Ashraf Hamed Al-Shokray; Asmaa Obada Ibrahim; Hatem Hamed Elshorbagy; Mohamed Gamal El Din Fathallah; Ahmed Mahmoud Attia; Akram Elshafey Elsadek
Journal:  Iran J Child Neurol       Date:  2021

9.  Allelic Distribution of Genes for Apolipoprotein E and MTHFR in Patients with Alzheimer's Disease and Their Epistatic Interaction.

Authors:  Stanislav Sutovsky; Robert Petrovic; Maria Fischerova; Viera Haverlikova; Barbara Ukropcova; Jozef Ukropec; Peter Turcani
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.